The global bone densitometer market size reached USD 334.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 475.2 Million by 2034, exhibiting a growth rate (CAGR) of 3.98% during 2026-2034.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2025
|
|
Forecast Years
|
2026-2034
|
|
Historical Years
|
2020-2025
|
|
Market Size in 2025
|
USD 334.3 Million |
|
Market Forecast in 2034
|
USD 475.2 Million |
| Market Growth Rate 2026-2034 | 3.98% |
A bone densitometer, also known as a DXA machine, refers to a device that utilizes a minimal dose of ionizing radiation to measure bone loss and the amount of calcium and other minerals in a bone segment. There are two types of DXA equipment, namely central and peripheral devices. The central devices are used to measure the bone density of the hip and spine, and are usually flat and broad, with an arm overhead. On the other hand, peripheral devices are smaller in size and are mainly used to check bone density in wrists, heels, or fingers. It is the standardized method of diagnosing osteoporosis, as it requires no special preparations and a relatively shorter duration than other procedures. It is also used for assessing an individual’s risk for developing osteoporotic fractures.

To get more information on this market Request Sample
One of the major drivers of the bone densitometer market is the rise in geriatric population who are highly susceptible to bone-related ailments. This, along with the growing incidents of fragility fracture, is significantly contributing to the market growth. Apart from this, these devices are crucial in diagnosing osteoporosis and osteopenia, owing to which they are widely utilized for bone density testing in several hospitals and healthcare clinics. Other factors, such as advancements in DXA scanners, which have enabled quicker and more accurate diagnosis, along with increasing investments to improve the existing healthcare infrastructure, are expected to further create a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bone densitometer market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on device type, technology, application and end-user.
Breakup by Device Type:

To get detailed segment analysis of this market Request Sample
Breakup by Technology:
Breakup by Application:
Breakup by End-User:
Breakup by Region:

To get more information on the regional analysis of this market Request Sample
The competitive landscape of the industry has also been examined with some of the key players being Ampall Co. Ltd., BeamMed Ltd., Diagnostic Medical Systems Group, Echolight S.P.A, GE Healthcare, Hologic Inc., Medonica Co. Ltd., Scanflex Healthcare AB, Swissray Global Healthcare Holding Ltd., etc.
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2034 |
| Units | Million USD |
| Segment Coverage | Device Type, Technology, Application, End-User, Region |
| Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered | Ampall Co. Ltd., BeamMed Ltd., Diagnostic Medical Systems Group, Echolight S.P.A, GE Healthcare, Hologic Inc., Medonica Co. Ltd., Scanflex Healthcare AB, Swissray Global Healthcare Holding Ltd. |
| Customization Scope | 10% Free Customization |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The bone densitometer market was valued at USD 334.3 Million in 2025.
The bone densitometer market is projected to exhibit a CAGR of 3.98% during 2026-2034, reaching a value of USD 475.2 Million by 2034.
The bone densitometer market is driven by rising prevalence of osteoporosis, increasing aging population, and growing awareness about early diagnosis of bone-related disorders. Technological advancements in imaging, supportive government initiatives, and expanding healthcare infrastructure further fuel demand, making bone densitometers essential for preventive care and effective treatment planning.
Some of the major players in the bone densitometer market include Ampall Co. Ltd., BeamMed Ltd., Diagnostic Medical Systems Group, Echolight S.P.A, GE Healthcare, Hologic Inc., Medonica Co. Ltd., Scanflex Healthcare AB, Swissray Global Healthcare Holding Ltd., etc.